Richard Alan Nathan DO

Clinical Trials

• SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01

  Completed

  Phase 2

• Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections Start of enrollment: 2007 Jan 01

  Completed

  Phase 2

• An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection Start of enrollment: 2019 Aug 02

  Recruiting

  Phase 2

• Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 Start of enrollment: 2020 Dec 14

  Terminated

  Phase 2

• Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects Start of enrollment: 2021 May 19

  Terminated

  Phase 3

• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis Start of enrollment: 2021 Feb 15

  COMPLETED

  PHASE3

• Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection Start of enrollment: 2021 Jan 05

  Active, not recruiting

  Phase 2

• A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients Start of enrollment: 2020 Oct 20

  Withdrawn

  Phase 1, Phase 2

• Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 Start of enrollment: 2020 Oct 21

  Terminated

  Phase 2

• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications Start of enrollment: 2018 Jan 21

  TERMINATED

  PHASE3

• Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD Start of enrollment: 2019 Feb 07

  Completed

  Phase 2

• Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) Start of enrollment: 2017 Apr 14

  Terminated

  Phase 2, Phase 3

• SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence Start of enrollment: 2016 Aug 01

  Completed

  Phase 1

• Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection Start of enrollment: 2019 Aug 29

  Completed

  Phase 2

• Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease Start of enrollment: 2006 Jul 20

  Completed

  Phase 2

• West Nile Virus Natural History Start of enrollment: 2003 Sep 01

  Completed

• Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Start of enrollment: 2009 Nov 01

  Completed

  Phase 2

• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Start of enrollment: 2007 Mar 08

  COMPLETED

  PHASE3

• Study of CB-183,315 in Participants With Clostridium Difficile Infection Start of enrollment: 2010 Apr 01

  Completed

  Phase 2

• IVIG - West Nile Encephalitis: Safety and Efficacy Start of enrollment: 2003 Sep 01

  Completed

  Phase 1, Phase 2

• Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci Start of enrollment: 2007 Jun 26

  Completed

  Phase 2

• Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults Start of enrollment: 2008 Oct 01

  Completed

  Phase 2

• A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza Start of enrollment: 2008 Jul 01

  Completed

  Phase 2

• Join now to see all